bethkis - tobramycin solution
(Tobramycin)Chiesi Usa, Inc.
Chiesi USA, Inc. drugs
15 results
cleviprex
(clevipidine)Chiesi USA, Inc.Usage: Cleviprex is indicated for lowering blood pressure in situations where oral medication is not feasible or desirable.curosurf
(poractant alfa)Chiesi USA, Inc.Usage: CUROSURF® (poractant alfa) is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants, helping to reduce mortality and the occurrence of pneumothoraces associated with the condition.elfabrio
(pegunigalsidase alfa)Chiesi USA, Inc.Usage: ELFABRIO is indicated for the treatment of adults with confirmed Fabry disease.ferriprox
(deferiprone)Chiesi USA, Inc.Usage: FERRIPROX Tablets are indicated for treating transfusional iron overload in adults and pediatric patients (8 years and older) with thalassemia syndromes, sickle cell disease, or other anemias. Safety and effectiveness are not established for myelodysplastic syndrome or Diamond Blackfan anemia.ferriprox
(deferiprone)Chiesi USA, Inc.Usage: FERRIPROX Tablets are indicated for treating transfusional iron overload in adults and pediatric patients (8 years and older) with thalassemia syndromes, sickle cell disease, or other anemias. Safety and effectiveness are not established for use in myelodysplastic syndrome or Diamond Blackfan anemia.ferriprox - deferiprone solution
(Deferiprone)Chiesi Usa, Inc.filsuvez - birch triterpenes gel
(Birch Triterpenes)Chiesi Usa, Inc.juxtapid - lomitapide mesylate capsule
(Lomitapide Mesylate)Chiesi Usa, Inc.kengreal
(cangrelor)Chiesi USA, Inc.Usage: KENGREAL is indicated as an adjunct to percutaneous coronary intervention (PCI) to lower the risk of periprocedural myocardial infarction, repeat coronary revascularization, and stent thrombosis in patients who have not received a P2Y12 platelet inhibitor and are not on a glycoprotein IIb/IIIa inhibitor.